Evidence map›Paper›PMID 37508488›Full record

ReviewCells2023

Golgi Apparatus Target Proteins in Gastroenterological Cancers: A Comprehensive Review of GOLPH3 and GOLGA Proteins.

Sandica Bucurica, Laura Gaman, Mariana Jinga, Andrei Adrian Popa, Florentina Ionita-Radu

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Role of Cannabinoids in Oral Cancer.International journal of molecular sciences · 2024
    Review
  6. Golgi defect as a major contributor to lysosomal dysfunction.Frontiers in cell and developmental biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sandica BucuricaDepartment of Gastroenterology, "Carol Davila" University of Medicine and Pharmacy Bucharest, 020021 Bucharest, Romania.ORCID 0000-0002-8787-3829
Laura GamanDepartment of Biochemistry, "Carol Davila" University of Medicine and Pharmacy Bucharest, 020021 Bucharest, Romania.
Mariana JingaDepartment of Gastroenterology, "Carol Davila" University of Medicine and Pharmacy Bucharest, 020021 Bucharest, Romania.
Andrei Adrian PopaStudent of General Medicine, "Carol Davila" University of Medicine and Pharmacy Bucharest, 020021 Bucharest, Romania.
Florentina Ionita-RaduDepartment of Gastroenterology, "Carol Davila" University of Medicine and Pharmacy Bucharest, 020021 Bucharest, Romania.ORCID 0000-0001-9829-5035
Carol Davila University of Medicine and Pharmacy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Golgi apparatus plays a central role in protein sorting, modification and trafficking within cells; its dysregulation has been implicated in various cancers including those affecting the GI tract. This review highlights two Golgi target proteins, namely GOLPH3 and GOLGA proteins, from this apparatus as they relate to gastroenterological cancers. GOLPH3-a highly conserved protein of the trans-Golgi network-has become a key player in cancer biology. Abnormal expression of GOLPH3 has been detected in various gastrointestinal cancers including gastric, colorectal and pancreatic cancers. GOLPH3 promotes tumor cell proliferation, survival, migration and invasion via various mechanisms including activating the PI3K/Akt/mTOR signaling pathway as well as altering Golgi morphology and vesicular trafficking. GOLGA family proteins such as GOLGA1 (golgin-97) and GOLGA7 (golgin-84) have also been implicated in gastroenterological cancers. GOLGA1 plays an essential role in protein trafficking within the Golgi apparatus and has been associated with poor patient survival rates and increased invasiveness; GOLGA7 maintains Golgi structure while having been shown to affect protein glycosylation processes. GOLPH3 and GOLGA proteins play a pivotal role in gastroenterological cancer, helping researchers unlock molecular mechanisms and identify therapeutic targets. Their dysregulation affects various cellular processes including signal transduction, vesicular trafficking and protein glycosylation, all contributing to tumor aggressiveness and progression.

Indexed as

NeoplasmsPhosphatidylinositol 3-KinasesGastrointestinal TractGolgi ApparatusHumansMembrane ProteinsGOLPH3 protein, humanMembrane ProteinsPhosphatidylinositol 3-KinasesGOLGA proteinsGolgi apparatusGolgi morphologyGOLPH3protein sortingtherapeutic targetstumor progression

Identifiers

PMID37508488
PMCPMC10378073
OpenAlexW4384037345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.